Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Large-scale testing (Phase 3)Study completedNCT00004154What this trial is testingFenretinide in Treating Patients Who Have Undergone Surgery for Bladder CancerWho this might be right forBladder Cancer M.D. Anderson Cancer Center 111
Large-scale testing (Phase 3)Ended earlyNCT00352079What this trial is testingBCG With or Without Gefitinib in Treating Patients With High-Risk Bladder CancerWho this might be right forBladder Cancer NCIC Clinical Trials Group 41
Not applicableWithdrawnNCT00084578What this trial is testingCelecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWho this might be right forBladder Cancer Fox Chase Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06704191What this trial is testingIn-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE TrialWho this might be right forNon-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+1 more Mayo Clinic 40
Not applicableUnknownNCT00553566What this trial is testingEffect of Dietary, Lifestyle, and Environmental Factors on Patients With Early-Stage Bladder CancerWho this might be right forBladder Cancer University of Birmingham 1,600
Large-scale testing (Phase 3)UnknownNCT00553345What this trial is testingSelenium and Vitamin E in Preventing Cancer Progression and Recurrence in Patients With Early-Stage Bladder CancerWho this might be right forBladder Cancer University of Birmingham 515
Testing effectiveness (Phase 2)Study completedNCT00003759What this trial is testingAD 32 With or Without BCG After Surgery in Treating Patients With Newly Diagnosed or Recurrent Superficial Bladder CancerWho this might be right forBladder Cancer Anthra Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT00002990What this trial is testingSurgery and BCG in Treating Patients With Bladder CancerWho this might be right forBladder Cancer European Organisation for Research and Treatment of Cancer - EORTC 1,288
Testing effectiveness (Phase 2)Study completedNCT00047216What this trial is testingTipifarnib in Treating Patients With Recurrent Bladder CancerWho this might be right forBladder Cancer University Health Network, Toronto
Not applicableActive Not RecruitingNCT06350734What this trial is testingQuality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship StudyWho this might be right forStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+2 more Mayo Clinic 204
Testing effectiveness (Phase 2)Study completedNCT03319745What this trial is testingPembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical CystectomyWho this might be right forStage I Bladder Cancer AJCC v8Stage II Bladder Cancer AJCC v8Stage III Bladder Cancer AJCC v8+2 more M.D. Anderson Cancer Center 23
Large-scale testing (Phase 3)Study completedNCT00003814What this trial is testingEflornithine in Treating Patients With Bladder CancerWho this might be right forBladder Cancer National Cancer Institute (NCI) 450
Large-scale testing (Phase 3)Study completedNCT00033436What this trial is testingRadiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder CancerWho this might be right forBladder Cancer Mount Vernon Cancer Centre at Mount Vernon Hospital 330
Not applicableEnded earlyNCT02494635What this trial is testingUltrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder CancerWho this might be right forBladder Papillary Urothelial CarcinomaStage 0a Bladder Urothelial CarcinomaStage 0is Bladder Urothelial Carcinoma+5 more University of Southern California 4
Not applicableStudy completedNCT00900276What this trial is testingBiomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy ParticipantsWho this might be right forBladder CancerKidney CancerTransitional Cell Cancer of the Renal Pelvis and Ureter+1 more Wake Forest University Health Sciences 5
Not applicableStudy completedNCT00095589What this trial is testingMicrosatellite Analysis of Urinary Sediment in Detecting Bladder CancerWho this might be right forBladder Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 125
Large-scale testing (Phase 3)UnknownNCT00553124What this trial is testingDifferent Factors Affecting Patients With Newly Diagnosed Bladder CancerWho this might be right forBladder Cancer University Hospital Birmingham 3,400
Early research (Phase 1)Active Not RecruitingNCT05843448What this trial is testingIDO and PD-L1 Peptide Based Immune-Modulatory Therapeutic (IO102-IO103) in Combination With Pembrolizumab for BCG-Unresponsive or Intolerant, Non-Muscle Invasive Bladder CancerWho this might be right forHigh Risk Non-Muscle Invasive Bladder Urothelial CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8+1 more University of California, Davis 6
Early research (Phase 1)Study completedNCT00003167What this trial is testingGene Therapy in Treating Patients With Advanced Bladder CancerWho this might be right forRecurrent Bladder CancerStage I Bladder CancerStage II Bladder Cancer+3 more National Cancer Institute (NCI) 24